First Hospital in the Northeastern U.S. Market to Install the Company's Surgical Guidance System
CAESAREA, Israel--Mazor Robotics Ltd. (TASE: MZOR; NASDAQCM: MZOR), a developer of innovative surgical robots and complementary products, today announced that St. Mary's Healthcare, a general medical and surgical hospital in Amsterdam, NY, has acquired its first Renaissance system. St. Mary's Hospital at Amsterdam is a member of Ascension Health. Ascension Health is the nation's largest Catholic and nonprofit health system with more than 105,000 associates serving in 20 states and the District of Columbia.
This purchase marks the first Renaissance system to be installed in the northeastern U.S., a region with a population in excess of 55 million people. The Company anticipates this will be a region for further penetration of its surgical guidance system.
"Mazor has clearly developed a technologically advanced system and we are delighted to be the first hospital in the northeast to offer the Renaissance system," commented Vic Giulianelli, President and CEO of St. Mary's. "Our patients already benefit from St. Mary's having one of the nation's leading orthopedic spine surgeon, and to achieve our goal of becoming a leading center for advanced spine surgery regionally and throughout the Northeast, we also need to take advantage of the latest technological advances, which we have now done with the purchase of the Renaissance system."
"St. Mary's Healthcare is a high quality institution - one that is committed to patient care and ensuring that its surgeons are continually using the latest technologies to deliver better patient outcomes," commented Ori Hadomi, Mazor's Chief Executive Officer. "Our initial success in California, Florida and Texas provides us with a body of evidence supporting the benefits of our Renaissance system, so we are delighted to have installed our first Renaissance system in the northeast. We will continue to deploy more resources to build upon this success as we see this being a promising market for Mazor."
"As surgeons, we are inherently looking for better solutions for our patients, and I believe Renaissance will enable us to better serve those suffering from debilitating spinal conditions," commented Jian Shen MD, Ph.D., a leading orthopedic spine surgeon. "Renaissance system is the safest, most accurate technology for minimally invasive spine surgery currently available in the marketplace, and given its accuracy and high safety level, I have complete confidence in its capabilities."
Renaissance, Mazor Robotics' next generation surgical guidance system for spine procedures, is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art guided procedures that raise the standard of care with better clinical results. Renaissance system has been used to perform thousands of procedures worldwide (with over 35,000 implants placed in those procedures) in a wide variety of spinal procedures, many of which would not have been attempted without this technology.
Mazor Robotics (TASE: MZOR; NASDAQCM: MZOR) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics' flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 35,000 implants in the United States and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, the content of which is not part of this press release, please visit www.mazorrobotics.com.